Trexquant Investment LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2023$2,428,163
-7.1%
147,340
-12.0%
0.07%
-9.5%
Q4 2022$2,613,125
+1401.8%
167,508
+1151.4%
0.07%
+1133.3%
Q3 2022$174,000
-73.8%
13,386
-71.7%
0.01%
-80.0%
Q2 2022$664,000
+45.3%
47,273
+41.0%
0.03%
+7.1%
Q4 2021$457,000
+69.3%
33,525
+122.4%
0.03%
+47.4%
Q2 2020$270,000
+21.6%
15,076
+34.1%
0.02%
+46.2%
Q4 2019$222,000
+21.3%
11,243
+5.5%
0.01%
-18.8%
Q3 2019$183,00010,6540.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders